• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

喜树碱的递送方法。

Camptothecin delivery methods.

作者信息

Hatefi A, Amsden B

机构信息

Faculty of Pharmacy, University of Alberta, Edmonton, Canada.

出版信息

Pharm Res. 2002 Oct;19(10):1389-99. doi: 10.1023/a:1020427227285.

DOI:10.1023/a:1020427227285
PMID:12425455
Abstract

Camptothecin has shown significant antitumor activity to lung, ovarian, breast, pancreas, and stomach cancers. Camptothecin, however, like a number of other potent anticancer agents such as paclitaxel, is extremely water insoluble. Furthermore, pharmacology studies have determined that prolonged schedules of administration given continuously are required. Thus, this insolubility has restricted its clinical application. For these reasons, a number of water-soluble analogs have been synthesized and a number of different formulation approaches have been investigated. In this review, we examine each of these approaches and discuss their advantages and limitations.

摘要

喜树碱已显示出对肺癌、卵巢癌、乳腺癌、胰腺癌和胃癌具有显著的抗肿瘤活性。然而,喜树碱与许多其他强效抗癌药物如紫杉醇一样,极难溶于水。此外,药理学研究已确定需要持续长时间给药。因此,这种不溶性限制了其临床应用。出于这些原因,人们合成了许多水溶性类似物,并研究了许多不同的制剂方法。在本综述中,我们研究了这些方法中的每一种,并讨论了它们的优点和局限性。

相似文献

1
Camptothecin delivery methods.喜树碱的递送方法。
Pharm Res. 2002 Oct;19(10):1389-99. doi: 10.1023/a:1020427227285.
2
The Advancement of Biodegradable Polyesters as Delivery Systems for Camptothecin and Its Analogues-A Status Report.可生物降解聚酯作为喜树碱及其类似物传递系统的进展——现状报告。
Int J Mol Sci. 2023 Jan 5;24(2):1053. doi: 10.3390/ijms24021053.
3
Efficient intracellular delivery of camptothecin by silica/titania hollow nanoparticles.介孔硅/二氧化钛空心纳米粒子高效递送至细胞内的喜树碱。
Chemistry. 2012 Apr 16;18(16):4902-8. doi: 10.1002/chem.201200043. Epub 2012 Mar 15.
4
Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38.前药和纳米医学方法用于递送喜树碱类似物 SN38。
J Control Release. 2013 Nov 28;172(1):48-61. doi: 10.1016/j.jconrel.2013.07.022. Epub 2013 Aug 6.
5
Camptothecins and lung cancer: improved delivery systems by aerosol.喜树碱与肺癌:通过气雾剂改善给药系统
Curr Cancer Drug Targets. 2003 Aug;3(4):251-64. doi: 10.2174/1568009033481930.
6
Preparation of camptothecin-loaded targeting nanoparticles and their antitumor effects on hepatocellular carcinoma cell line H22.载喜树碱靶向纳米粒的制备及其对肝癌 H22 细胞的抗肿瘤作用。
Drug Deliv. 2016 Jun;23(5):1699-706. doi: 10.3109/10717544.2014.950767. Epub 2014 Aug 22.
7
Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery.聚合物和两亲性环糊精纳米粒用于有效喜树碱传递的比较评价。
Eur J Pharm Biopharm. 2009 Sep;73(1):82-9. doi: 10.1016/j.ejpb.2009.04.013. Epub 2009 May 13.
8
Targeting tumor cells through chitosan-folate modified microcapsules loaded with camptothecin.通过载有喜树碱的壳聚糖-叶酸修饰微胶囊靶向肿瘤细胞。
Bioconjug Chem. 2011 Jun 15;22(6):1066-72. doi: 10.1021/bc100546s. Epub 2011 May 18.
9
Preparation and evaluation of lipid vesicles of camptothecin as targeted drug delivery system.喜树碱脂质体作为靶向给药系统的制备与评价
Pak J Pharm Sci. 2013 Jul;26(4):779-86.
10
Safe approaches for camptothecin delivery: Structural analogues and nanomedicines.喜树碱给药的安全方法:结构类似物和纳米药物。
J Control Release. 2017 Feb 10;247:28-54. doi: 10.1016/j.jconrel.2016.12.023. Epub 2016 Dec 24.

引用本文的文献

1
Camptothein-Based Anti-Cancer Therapies and Strategies to Improve Their Therapeutic Index.基于喜树碱的抗癌疗法及提高其治疗指数的策略。
Cancers (Basel). 2025 Mar 20;17(6):1032. doi: 10.3390/cancers17061032.
2
Nonconventional Techniques in Plant Alkaloid Extraction: A Decade of Progress (2014-2023).植物生物碱提取中的非常规技术:十年进展(2014 - 2023)
Chem Biodivers. 2025 Mar 21:e202403225. doi: 10.1002/cbdv.202403225.
3
Spectroscopic and molecular docking studies on binding interactions of camptothecin drugs with bovine serum albumin.

本文引用的文献

1
Treatment of visceral leishmaniasis with sterically stabilized liposomes containing camptothecin.用含有喜树碱的空间稳定脂质体治疗内脏利什曼病。
Antimicrob Agents Chemother. 2001 Sep;45(9):2623-7. doi: 10.1128/AAC.45.9.2623-2627.2001.
2
Effects of 10-hydroxycamptothecin, delivered from locally injectable poly(lactide-co-glycolide) microspheres, in a murine human oral squamous cell carcinoma regression model.从局部可注射聚(丙交酯-共-乙交酯)微球中释放的10-羟基喜树碱在小鼠人口腔鳞状细胞癌消退模型中的作用。
Anticancer Res. 2001 May-Jun;21(3B):1713-22.
3
Water-soluble poly-(L-glutamic acid)-Gly-camptothecin conjugates enhance camptothecin stability and efficacy in vivo.
喜树碱类药物与牛血清白蛋白结合相互作用的光谱学和分子对接研究
Sci Rep. 2025 Mar 7;15(1):8055. doi: 10.1038/s41598-025-92607-3.
4
Curcumin in Cancer Prevention: Insights from Clinical Trials and Strategies to Enhance Bioavailability.姜黄素在癌症预防中的作用:来自临床试验的见解及提高生物利用度的策略
Curr Pharm Des. 2024;30(23):1838-1851. doi: 10.2174/0113816128303514240517054617.
5
Progress in oncolytic viruses modified with nanomaterials for intravenous application.纳米材料修饰的溶瘤病毒在静脉给药方面的研究进展。
Cancer Biol Med. 2023 Nov 24;20(11):830-55. doi: 10.20892/j.issn.2095-3941.2023.0275.
6
Poly(amidoamine) Dendrimer/Camptothecin Complex: From Synthesis to In Vitro Cancer Cell Line Studies.聚酰胺-胺树枝状大分子/喜树碱复合物:从合成到体外癌细胞系研究。
Molecules. 2023 Mar 16;28(6):2696. doi: 10.3390/molecules28062696.
7
Poly(l-lactide--caprolactone--glycolide)-Based Nanoparticles as Delivery Platform: Effect of the Surfactants on Characteristics and Delivery Efficiency.基于聚(L-丙交酯-己内酯-乙交酯)的纳米颗粒作为递送平台:表面活性剂对特性和递送效率的影响
Nanomaterials (Basel). 2022 May 3;12(9):1550. doi: 10.3390/nano12091550.
8
SN38 loaded nanostructured lipid carriers (NLCs); preparation and in vitro evaluations against glioblastoma.载有 SN38 的纳米结构脂质载体(NLCs)的制备及其对神经胶质瘤的体外评价。
J Mater Sci Mater Med. 2021 Jun 30;32(7):78. doi: 10.1007/s10856-021-06538-2.
9
Nanovectorization of Prostate Cancer Treatment Strategies: A New Approach to Improved Outcomes.前列腺癌治疗策略的纳米矢量化:改善治疗结果的新方法。
Pharmaceutics. 2021 Apr 21;13(5):591. doi: 10.3390/pharmaceutics13050591.
10
A novel microfluidic liposomal formulation for the delivery of the SN-38 camptothecin: characterization and in vitro assessment of its cytotoxic effect on two tumor cell lines.一种新型的载 SN-38 喜树碱的脂质体微流控制剂:对两种肿瘤细胞系的细胞毒性作用的表征和体外评估。
Int J Nanomedicine. 2018 Sep 11;13:5301-5320. doi: 10.2147/IJN.S166219. eCollection 2018.
水溶性聚(L-谷氨酸)-甘氨酸-喜树碱缀合物可增强喜树碱在体内的稳定性和疗效。
J Control Release. 2001 Jul 6;74(1-3):243-7. doi: 10.1016/s0168-3659(01)00323-6.
4
Biorecognizable HPMA copolymer-drug conjugates for colon-specific delivery of 9-aminocamptothecin.用于9-氨基喜树碱结肠特异性递送的生物可识别性HPMA共聚物-药物缀合物
J Control Release. 2001 Aug 10;75(3):365-79. doi: 10.1016/s0168-3659(01)00405-9.
5
Improved dissolution and cytotoxicity of camptothecin incorporated into oxidized-cellulose microspheres prepared by spray drying.通过喷雾干燥制备的喜树碱负载于氧化纤维素微球中的药物,其溶出度和细胞毒性得到改善。
Pharm Dev Technol. 2001 Aug;6(3):459-67. doi: 10.1081/pdt-100002254.
6
Improved respiratory delivery of the anticancer drugs, camptothecin and paclitaxel, with 5% CO2-enriched air: pharmacokinetic studies.使用富含5%二氧化碳的空气改善抗癌药物喜树碱和紫杉醇的呼吸道给药:药代动力学研究
Cancer Chemother Pharmacol. 2001 May;47(5):451-6. doi: 10.1007/s002800000230.
7
Unusual potency of BN 80915, a novel fluorinated E-ring modified camptothecin, toward human colon carcinoma cells.新型氟化E环修饰喜树碱BN 80915对人结肠癌细胞具有异常强效的作用。
Cancer Res. 2001 Apr 1;61(7):2961-7.
8
Carrier and dose effects on the pharmacokinetics of T-0128, a camptothecin analogue-carboxymethyl dextran conjugate, in non-tumor- and tumor-bearing rats.载体和剂量对喜树碱类似物-羧甲基葡聚糖偶联物T-0128在非荷瘤和荷瘤大鼠体内药代动力学的影响。
J Control Release. 2001 Mar 12;71(1):71-86. doi: 10.1016/s0168-3659(00)00372-2.
9
9-Nitrocamptothecin liposome aerosol treatment of human cancer subcutaneous xenografts and pulmonary cancer metastases in mice.9-硝基喜树碱脂质体气雾剂对小鼠人癌皮下异种移植瘤和肺癌转移灶的治疗作用
Ann N Y Acad Sci. 2000;922:151-63. doi: 10.1111/j.1749-6632.2000.tb07033.x.
10
Conjugation of camptothecins to poly-(L-glutamic acid).喜树碱与聚-L-谷氨酸的共轭反应。
Ann N Y Acad Sci. 2000;922:136-50. doi: 10.1111/j.1749-6632.2000.tb07032.x.